{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:16:53Z","timestamp":1714781813761},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/bf03262279","type":"journal-article","created":{"date-parts":[[2012,12,23]],"date-time":"2012-12-23T18:47:40Z","timestamp":1356288460000},"page":"627-637","source":"Crossref","is-referenced-by-count":1,"title":["The Efficacy and Safety of Newer Anticonvulsants in Patients with Dementia"],"prefix":"10.1007","volume":"29","author":[{"given":"Christian R.","family":"Dolder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly L.","family":"Nealy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,23]]},"reference":[{"key":"2279_CR1","unstructured":"American Psychiatric Association: Treatment of patients with Alzheimer\u2019s disease and other dementias. 2nd ed. 2007 Oct [online]. Available from URL: http:\/\/psychiatryonline.org\/data\/Books\/prac\/AlzPG101007.pdf [Accessed 2011 Oct 4]."},{"key":"2279_CR2","unstructured":"American Academy of Neurology. Practice parameter: management of dementia. 2003 Oct [online]. Available from URL: http:\/\/www.neurology.org\/content\/56\/9\/1154.full.pdf [Accessed 2011 Oct 4]."},{"issue":"7","key":"2279_CR3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.JGP.0000221334.65330.55","volume":"14","author":"C.G. Lyketsos","year":"2006","unstructured":"Lyketsos CG, Colenda CC, Beck C, et al. Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry 2006 Jul; 14 (7): 561\u201372.","journal-title":"Am J Geriatr Psychiatry"},{"key":"2279_CR4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jamda.2009.10.001","volume":"11","author":"J.J. Jalbert","year":"2010","unstructured":"Jalbert JJ, Eaton CB, Miller SC. Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia. J Am Med Dir Assoc 2010; 11: 120\u20137.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"2279_CR5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1532-5415.1999.tb01899.x","volume":"47","author":"R.M. Leipzig","year":"1999","unstructured":"Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 1999 Jan; 47 (1): 40\u201350.","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"2279_CR6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2165\/11537890-000000000-00000","volume":"27","author":"S. Mehta","year":"2010","unstructured":"Mehta S, Chen H, Johnson ML, et al. Risk of falls and fractures in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. Drugs Aging 2010 Oct 1; 27 (10): 815\u201329.","journal-title":"Drugs Aging"},{"issue":"6","key":"2279_CR7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4088\/JCP.09m05817yel","volume":"71","author":"S. Mehta","year":"2010","unstructured":"Mehta S, Johnson ML, Chen H, et al. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. J Clin Psychiatry 2010 Jun; 71 (6): 689\u201398.","journal-title":"J Clin Psychiatry"},{"key":"2279_CR8","doi-asserted-by":"crossref","first-page":"c4245","DOI":"10.1136\/bmj.c4245","volume":"341","author":"C. Parker","year":"2010","unstructured":"Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ 2010 Sep 21; 341: c4245.","journal-title":"BMJ"},{"issue":"6","key":"2279_CR9","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1532-5415.2010.02873.x","volume":"58","author":"R.C. Rossom","year":"2010","unstructured":"Rossom RC, Rector TS, Lederle FA, et al. Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia? J Am Geriatr Soc 2010 Jun; 58 (6): 1027\u201334.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2279_CR10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","volume":"14","author":"L.S. Schneider","year":"2006","unstructured":"Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006 Mar; 14 (3): 191\u2013210.","journal-title":"Am J Geriatr Psychiatry"},{"key":"2279_CR11","unstructured":"United States Food and Drug Administration. Information for healthcare professionals: conventional antipsychotics. 2008 Jun 16 [online]. Available from URL: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm124830.htm [Accessed 2011 Feb 4]."},{"issue":"3","key":"2279_CR12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","volume":"360","author":"W.A. Ray","year":"2009","unstructured":"Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009 Jan 15; 360 (3): 225\u201335.","journal-title":"N Engl J Med"},{"issue":"12","key":"2279_CR13","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/gps.1811","volume":"22","author":"E.J. Bierman","year":"2007","unstructured":"Bierman EJ, Comijs HC, Gundy CM, et al. The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent? Int J Geriatr Psychiatry 2007 Dec; 22 (12): 1194\u2013200.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"2279_CR14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1532-5415.2005.00571.x","volume":"54","author":"S.L. Gray","year":"2006","unstructured":"Gray SL, LaCroix AZ, Hanlon JT, et al. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc 2006 Feb; 54 (2): 224\u201330.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"2279_CR15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002018-199921020-00004","volume":"21","author":"S.L. Gray","year":"1999","unstructured":"Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf 1999 Aug; 21 (2): 101\u201322.","journal-title":"Drug Saf"},{"issue":"15","key":"2279_CR16","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2146\/ajhp090611","volume":"67","author":"S.M. Lavsa","year":"2010","unstructured":"Lavsa SM, Fabian TJ, Saul MI, et al. Influence of medications and diagnoses on fall risk in psychiatric inpatients. Am J Health Syst Pharm 2010 Aug; 67 (15): 1274\u201380.","journal-title":"Am J Health Syst Pharm"},{"issue":"14","key":"2279_CR17","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/archinte.164.14.1567","volume":"164","author":"A.K. Wagner","year":"2004","unstructured":"Wagner AK, Zhang F, Soumerai SB, et al. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Int Med 2004 Jul 26; 164 (14): 1567\u201372.","journal-title":"Arch Int Med"},{"issue":"21","key":"2279_CR18","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","volume":"169","author":"J.C. Woolcott","year":"2009","unstructured":"Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Int Med 2009 Nov 23; 169 (21): 1952\u201360.","journal-title":"Arch Int Med"},{"issue":"3","key":"2279_CR19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.159.3.460","volume":"159","author":"B.G. Pollock","year":"2002","unstructured":"Pollock BG, Mulsant BH, Rosen J, et al. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry 2002 Mar; 159 (3): 460\u20135.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"2279_CR20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00019442-199705010-00009","volume":"5","author":"B.G. Pollock","year":"1997","unstructured":"Pollock BG, Mulsant BH, Sweet R, et al. An open pilot study of citalopram for behavioral disturbances of dementia: plasma levels and real-time observations. Am J Geriatr Psychiatry 1997 Winter; 5 (1): 70\u20138.","journal-title":"Am J Geriatr Psychiatry"},{"key":"2279_CR21","doi-asserted-by":"crossref","unstructured":"Dolder CR, Nealy KL, McKinsey J. Valproic acid in dementia: Does an optimal dose exist? J Pharm Pract. Epub 2011 Nov 17.","DOI":"10.1177\/0897190011424802"},{"issue":"3","key":"2279_CR22","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/j.1875-9114.1998.tb03122.x","volume":"18","author":"F. Grossman","year":"1998","unstructured":"Grossman F. A review of anticonvulsants in treating agitated demented elderly patients. Pharmacotherapy 1998 May\u2013Jun; 18 (3): 600\u20136.","journal-title":"Pharmacotherapy"},{"issue":"10","key":"2279_CR23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/070674370705201004","volume":"52","author":"N. Herrmann","year":"2007","unstructured":"Herrmann N, Lanctot KL. Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease. Can J Psychiatry 2007 Oct; 52 (10): 630\u201346.","journal-title":"Can J Psychiatry"},{"issue":"11","key":"2279_CR24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00002512-200623110-00003","volume":"23","author":"A.P. Porsteinsson","year":"2006","unstructured":"Porsteinsson AP. Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderly. Drugs Aging 2006; 23 (11): 877\u201386.","journal-title":"Drugs Aging"},{"issue":"5","key":"2279_CR25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.293.5.596","volume":"293","author":"K.M. Sink","year":"2005","unstructured":"Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005 Feb 2; 293 (5): 596\u2013608.","journal-title":"JAMA"},{"key":"2279_CR26","doi-asserted-by":"crossref","unstructured":"Tariot PN, Schneider LS, Cummings J, et al. Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease. Arch Gen Psychiatry Aug; 68 (8): 853\u201361.","DOI":"10.1001\/archgenpsychiatry.2011.72"},{"key":"2279_CR27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-0179-5-14","volume":"5","author":"B. Amann","year":"2009","unstructured":"Amann B, Pantel J, Grunze H, et al. Anticonvulsants in the treatment of aggression in the demented elderly: an update. Clin Pract Epidemiol Ment Health 2009; 5: 14.","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"12","key":"2279_CR28","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.4140\/TCP.n.2007.1004","volume":"22","author":"D.R. Guay","year":"2007","unstructured":"Guay DR. Newer antiepileptic drugs in the management of agitation\/aggression in patients with dementia or developmental disability. Consult Pharm 2007 Dec; 22 (12): 1004\u201334.","journal-title":"Consult Pharm"},{"issue":"2","key":"2279_CR29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1517\/14740338.6.2.133","volume":"6","author":"B.R. Sommer","year":"2007","unstructured":"Sommer BR, Fenn HH, Ketter TA. Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin. Expert Opin Drug Saf 2007 Mar; 6 (2): 133\u201345.","journal-title":"Expert Opin Drug Saf"},{"issue":"10","key":"2279_CR30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/gps.1784","volume":"22","author":"M. Sajatovic","year":"2007","unstructured":"Sajatovic M, Ramsay E, Nanry K, et al. Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. Int J Geriatr Psychiatry 2007 Oct; 22 (10): 945\u201350.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"9","key":"2279_CR31","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1212\/WNL.36.9.1226","volume":"36","author":"W.A. Hauser","year":"1986","unstructured":"Hauser WA, Morris ML, Heston LL, et al. Seizures and myoclonus in patients with Alzheimer\u2019s disease. Neurology 1986 Sep; 36 (9): 1226\u201330.","journal-title":"Neurology"},{"issue":"3","key":"2279_CR32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1212\/WNL.46.3.727","volume":"46","author":"D.C. Hesdorffer","year":"1996","unstructured":"Hesdorffer DC, Hauser WA, Annegers JF, et al. Dementia and adult-onset unprovoked seizures. Neurology 1996 Mar; 46 (3): 727\u201330.","journal-title":"Neurology"},{"issue":"1","key":"2279_CR33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12017-009-8076-z","volume":"12","author":"A.J. Larner","year":"2010","unstructured":"Larner AJ. Epileptic seizures in AD patients. Neuromolecular Med 2010 Mar; 12 (1): 71\u20137.","journal-title":"Neuromolecular Med"},{"issue":"8","key":"2279_CR34","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archneur.1990.00530080029006","volume":"47","author":"M.F. Romanelli","year":"1990","unstructured":"Romanelli MF, Morris JC, Ashkin K, et al. Advanced Alzheimer\u2019s disease is a risk factor for late-onset seizures. Arch Neurol 1990 Aug; 47 (8): 847\u201350.","journal-title":"Arch Neurol"},{"issue":"3","key":"2279_CR35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1528-1157.1996.tb00017.x","volume":"37","author":"L. Forsgren","year":"1996","unstructured":"Forsgren L, Bucht G, Eriksson S, et al. Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia 1996 Mar; 37 (3): 224\u20139.","journal-title":"Epilepsia"},{"issue":"5","key":"2279_CR36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF03324726","volume":"19","author":"C. Hommet","year":"2007","unstructured":"Hommet C, Hureaux R, Barre J, et al. Epileptic seizures in clinically diagnosed Alzheimer\u2019s disease: report from a geriatric medicine population. Aging Clin Exp Res 2007 Oct; 19 (5): 430\u20131.","journal-title":"Aging Clin Exp Res"},{"issue":"11","key":"2279_CR37","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2165\/00002512-200320110-00001","volume":"20","author":"M. Mendez","year":"2003","unstructured":"Mendez M, Lim G. Seizures in elderly patients with dementia: epidemiology and management. Drugs Aging 2003; 20 (11): 791\u2013803.","journal-title":"Drugs Aging"},{"issue":"1","key":"2279_CR38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.yebeh.2008.08.012","volume":"14","author":"S.C. Rao","year":"2009","unstructured":"Rao SC, Dove G, Cascino GD, et al. Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome. Epilepsy Behav 2009 Jan; 14 (1): 118\u201320.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"2279_CR39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"G.M. McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 2011 May; 7 (3): 263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"2279_CR40","first-page":"548","volume":"69","author":"M.H. Ebell","year":"2004","unstructured":"Ebell MH, Siwek J, Weiss BD, et al. Strength of Recommendation Taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician 2004 Feb 1; 69 (3): 548\u201356.","journal-title":"Am Fam Physician"},{"issue":"2","key":"2279_CR41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000199236","volume":"27","author":"O.H. Sommer","year":"2009","unstructured":"Sommer OH, Aga O, Cvancarova M, et al. Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. Dement Geriatr Cogn Disord 2009; 27 (2): 155\u201363.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"2279_CR42","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","volume":"17","author":"E. Cumbo","year":"2010","unstructured":"Cumbo E, Ligori LD. Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer\u2019s disease. Epilepsy Behav 2010 Apr; 17 (4): 461\u20136.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"2279_CR43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1533317508325095","volume":"25","author":"C.F. Lippa","year":"2010","unstructured":"Lippa CF, Rosso A, Hepler M, et al. Levetiracetam: a practical option for seizure management in elderly patients with cognitive impairment. Am J Alzheimers Dis Other Demen 2010 Mar; 25 (2): 149\u201354.","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"4","key":"2279_CR44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/01.jcp.0000264996.08901.3c","volume":"27","author":"H.H. Kyomen","year":"2007","unstructured":"Kyomen HH, Whitfield TH, Baldessarini RJ. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer\u2019s type. J Clin Psychopharmacol 2007 Aug; 27 (4): 408\u201310.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"2279_CR45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S1041610205212061","volume":"17","author":"M.F. Weiner","year":"2005","unstructured":"Weiner MF, Womack KB, Martin-Cook K, et al. Levetiracetam for agitated Alzheimer\u2019s disease patients. Int Psychogeriatr 2005 Jun; 17 (2): 327\u20138.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"2279_CR46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/JCP.0b013e3181ca0c59","volume":"30","author":"A. Mowla","year":"2010","unstructured":"Mowla A, Pani A. Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial. J Clin Psychopharmacol 2010 Feb; 30 (1): 40\u20133.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"2279_CR47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S1041610203009554","volume":"15","author":"B. Fhager","year":"2003","unstructured":"Fhager B, Meiri IM, Sjogren M, et al. Treatment of aggressive behavior in dementia with the anticonvulsant to-piramate: a retrospective pilot study. Int Psychogeriatr 2003 Sep; 15 (3): 307\u20139.","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"2279_CR48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1440-1819.2010.02075.x","volume":"64","author":"T. Odawara","year":"2010","unstructured":"Odawara T, Shiozaki K, Togo T, et al. Administration of zonisamide in three cases of dementia with Lewy bodies. Psychiatry Clin Neurosci 2010 Jun; 64 (3): 327\u20139.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"6","key":"2279_CR49","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.pnpbp.2010.04.018","volume":"34","author":"S. Sato","year":"2010","unstructured":"Sato S, Mizukami K, Asada T. Successful treatment of extrapyramidal and psychotic symptoms with zonisamide in a patient with dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry 2010 Aug 16; 34 (6): 1130\u20131.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"10","key":"2279_CR50","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1468-1331.2007.01907.x","volume":"14","author":"V. Belcastro","year":"2007","unstructured":"Belcastro V, Costa C, Galletti F, et al. Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study. Eur J Neurol 2007 Oct; 14 (10): 1176\u20138.","journal-title":"Eur J Neurol"},{"issue":"11","key":"2279_CR51","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/mds.21061","volume":"21","author":"T.A. Zesiewicz","year":"2006","unstructured":"Zesiewicz TA, Sullivan KL, Hauser RA, et al. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington\u2019s disease. Mov Disord 2006 Nov; 21 (11): 1998\u20132001.","journal-title":"Mov Disord"},{"key":"2279_CR52","unstructured":"US National Institutes of Health. ClinicalTrials.gov [online]. Available from URL: http:\/\/www.clinicaltrials.gov [Accessed 2011 Oct 4]."},{"issue":"2","key":"2279_CR53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1525-5050(03)00037-4","volume":"4","author":"E. Kutluay","year":"2003","unstructured":"Kutluay E, McCague K, D\u2019Souza J, et al. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav 2003 Apr; 4 (2): 175\u201380.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"2279_CR54","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.mcna.2011.02.004","volume":"95","author":"I.M. Chapman","year":"2011","unstructured":"Chapman IM. Weight loss in older persons. Med Clin North Am 2011 May; 95 (3): 579\u201393, xi.","journal-title":"Med Clin North Am"},{"issue":"1","key":"2279_CR55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1212\/01.wnl.0000250236.75053.16","volume":"68","author":"M. Murata","year":"2007","unstructured":"Murata M, Hasegawa K, Kanazawa I. Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study. Neurology 2007 Jan 2; 68 (1): 45\u201350.","journal-title":"Neurology"},{"issue":"4","key":"2279_CR56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1528-1157.44.s4.3.x","volume":"44","author":"A.P. Aldenkamp","year":"2003","unstructured":"Aldenkamp AP, De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003; 44 Suppl. 4: 21\u20139.","journal-title":"Epilepsia"},{"issue":"1","key":"2279_CR57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/wnf.0b013e31815947b6","volume":"31","author":"A.P. Sempere","year":"2008","unstructured":"Sempere AP, Medrano V, Berenguer-Ruiz L. Reversible dementia secondary to topiramate. Clin Neuropharmacol 2008 Jan-Feb; 31 (1): 62.","journal-title":"Clin Neuropharmacol"},{"key":"2279_CR58","unstructured":"Lexicomp Online [subscription, online database]. Hudson (OH): Lexi-Comp, Inc., 2012 [online]. Available from URL: http:\/\/www.lexi.com [Accessed 2011 Feb 4]."},{"issue":"1","key":"2279_CR59","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1528-1167.2006.00376.x","volume":"47","author":"A. Cicolin","year":"2006","unstructured":"Cicolin A, Magliola U, Giordano A, et al. Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers. Epilepsia 2006 Jan; 47 (1): 82\u20135.","journal-title":"Epilepsia"},{"issue":"1","key":"2279_CR60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eplepsyres.2005.09.023","volume":"68","author":"K.J. Meador","year":"2006","unstructured":"Meador KJ. Cognitive and memory effects of the new antiepileptic drugs. Epilepsy Res 2006 Jan; 68 (1): 63\u20137.","journal-title":"Epilepsy Res"},{"issue":"4","key":"2279_CR61","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00003088-200645040-00002","volume":"45","author":"E. Perucca","year":"2006","unstructured":"Perucca E. Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age. Clin Pharmacokinet 2006; 45 (4): 351\u201363.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"2279_CR62","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0278-5846(95)00022-N","volume":"19","author":"L.G. Neyens","year":"1995","unstructured":"Neyens LG, Alpherts WC, Aldenkamp AP. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 1995 May; 19 (3): 411\u20139.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"2279_CR63","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1059-1311(03)00070-0","volume":"13","author":"T.M. Alsaadi","year":"2004","unstructured":"Alsaadi TM, Koopmans S, Apperson M, et al. Levetiracetam monotherapy for elderly patients with epilepsy. Seizure 2004 Jan; 13 (1): 58\u201360.","journal-title":"Seizure"},{"issue":"2\u20133","key":"2279_CR64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2003.08.010","volume":"56","author":"J.A. Cramer","year":"2003","unstructured":"Cramer JA, Leppik IE, Rue KD, et al. Tolerability of levetiracetam in elderly patients with CNS disorders. Epilepsy Res 2003 Oct; 56 (2\u20133): 135\u201345.","journal-title":"Epilepsy Res"},{"issue":"1","key":"2279_CR65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1034\/j.1399-5618.1999.10111.x","volume":"1","author":"K.N. Chengappa","year":"1999","unstructured":"Chengappa KN, Rathore D, Levine J, et al. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999 Sep; 1 (1): 42\u201353.","journal-title":"Bipolar Disord"},{"issue":"1","key":"2279_CR66","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/j.1528-1157.2000.tb02165.x","volume":"41","author":"H.S. White","year":"2000","unstructured":"White HS, Brown SD, Woodhead JH, et al. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 2000; 41 Suppl. 1: S17\u201320.","journal-title":"Epilepsia"},{"key":"2279_CR67","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.med.53.082901.103933","volume":"53","author":"P.B. Mitchell","year":"2002","unstructured":"Mitchell PB, Malhi GS. The expanding pharmacopoeia for bipolar disorder. Annu Rev Med 2002; 53: 173\u201388.","journal-title":"Annu Rev Med"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03262279.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03262279\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03262279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T23:57:37Z","timestamp":1714780657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03262279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["2279"],"URL":"https:\/\/doi.org\/10.1007\/bf03262279","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}